This retrospective cross-sectional analysis reviewed pharmaceutical ledger data from 29 public primary healthcare (PHC) facilities in Mkinga District, Tanga Region, Tanzania, covering 2019–2023. The sample comprised 26 dispensaries and 3 health centers. The study examined 33 selected commodities used to manage animal-related injuries, including biologicals and emergency medicines.
Overall availability across the study period remained below the WHO target of greater than 80%. Although the authors report an incremental improvement in availability in 2023, marked variability remained between facility types for several critical items. Reported availability contrasts include snake antivenom (34.6% in dispensaries vs 100% in health centers), anti-rabies biologicals (23.1% vs 66.7%), adrenaline injection (73.1% vs 100%), and dexamethasone injection (0% vs 66.7%). These differences indicate that patients presenting at dispensaries are less likely to find essential commodities on site compared with those who present at health centers.
The analysis documented frequency of stockouts and the duration of the longest stockout events across the five-year window. Dispensaries experienced more frequent stockouts between 2019 and 2021. An example reported was chlorpheniramine tablets with up to a 53.8% stockout rate in dispensaries. The single longest stockout recorded in the dataset was 218 days for an IV giving set in 2019 at a dispensary.
Health centers exhibited higher stockout rates in later years, particularly between 2021 and 2022. The study reports up to a 66.7% stockout rate for hydrocortisone injection in health centers in 2021. The longest stockout period reported for a health center item was 102 days for dexamethasone injection in 2020. These data show both facility types experienced prolonged interruptions in supply, but the timing and affected commodities differed.
Affordability was estimated using the daily wage of the lowest-paid government worker and applying a 7% of daily income threshold for healthcare expenditure. Using this approach, nearly all assessed commodities were classified as unaffordable for a person earning the lowest public-sector wage. The manuscript emphasizes that financial barriers are likely to limit access to life-saving treatments for animal-related injuries, compounding the effects of limited availability and stockouts at PHC facilities.
Across the five-year review, dispensaries were disproportionately affected by low availability and early-period stockouts (2019–2021). Health centers showed better availability for several high-priority items but experienced significant stockouts in 2021–2022 for some essential injections. Specific contrasts highlighted in the analysis include full availability in 2023 for snake antivenom at health centers versus a third-level availability at dispensaries, and markedly higher presence of adrenaline injection at health centers than at dispensaries.
These inter-facility differences suggest that organizational capacity, procurement practices, storage, or prioritization at higher-level PHC facilities may account for better access to some commodities. The reported data do not provide causal explanations for these differences; the source indicates only observed patterns from the ledger review.
The authors conclude that essential commodities for managing animal-related injuries remain inadequately available, frequently out of stock, and largely unaffordable at rural PHC facilities in the study area. Shortages were particularly notable for anti-rabies biologicals and snake antivenom, both of which are critical to prevent deaths and complications after animal exposures.
To address these gaps, the study recommends strengthening surveillance, forecasting, procurement, financing, and supply-chain systems. It also advocates expanding financial risk protection through health insurance schemes and targeted subsidies to reduce out-of-pocket barriers and improve equitable access to life-saving commodities.
The source frames these measures as necessary to ensure timely administration of safe, affordable, and effective medications that can prevent deaths and complications resulting from animal-related injuries.
The study used a retrospective cross-sectional design and analyzed pharmaceutical ledger records for 29 public PHC facilities (26 dispensaries and 3 health centers) in Mkinga District, Tanga Region, Tanzania. Data covered the period 2019–2023 and included availability, stockout events, and commodity prices for the 33 selected items. Affordability calculations used the wage of the lowest-paid government worker per day and a predefined 7% daily-income threshold for healthcare spending.
Ethical approval was obtained from the Muhimbili University of Health and Allied Sciences Research and Ethics Committee (Approval No. MUHAS-REC-07-2023-1813). Permissions were granted by the Ministry, the Tanga region, and Mkinga district administration. The authors state that the datasets used in the study are available from the corresponding author on reasonable request.
The manuscript is a preprint and has not undergone peer review. The source supplies observed availability, stockout, and affordability data but does not provide causal analyses or interventions. Any further operational or epidemiologic conclusions beyond the reported ledger findings were not presented in the source.